Welcome to the geko website

geko™ device

2018 marks the launch of our new website. We hope you like the fresh new look and improved navigation. The site places our clinical partners centre stage, and shines a light on their compelling research and readiness to embrace innovation to establish new therapies that address significant unmet need.

Wound therapy

Countess of Chester Hospital
NHS Foundation Trust

Accelerating closure of hard-to-heal complex wounds

Read Less

Following NICE guidance (MTG19)1 recommending use of the geko™ device for VTE prophylaxis, we have adopted the geko™ for high-risk VTE patients where drugs or other mechanical methods of VTE prevention are contraindicated or impractical.

Through targeted evaluations, I have also explored use of the geko™ in the healing process for patients with chronic venous insufficiency. Of note, was the introduction of geko™ as an adjunct therapy in the care regime of Mr Gordon Vickers, a patient with a hard-to-heal mixed aetiology ulcer, where pain and immobility had impacted the severity of his leg ulceration.

Hospitalized twice over a 6 month period, geko™ device usage was introduced at week 35 and controlled to 6 hours a day, five days a week. The combined geko™ + compression wound therapy delivered a significant reduction in the observed oedema and an accelerated wound healing process, resulting in total wound closure at week 23 post geko™ introduction2.

Mr Vickers treatment, also comprised of strong analgesia and antibiotics delivered intravenously, requiring hospital stays. Following geko™ use he reported improvements to quality of life and verbal pain rating, going from severe pain, to moderate, to low pain on treatment completion”.

Comment – Mr Vickers

“The geko™ was fitted above my compression bandage.  At that time, I was willing to try anything to help heal my wound. On discharge from hospital the nursing team thought I might never recover. My wound did though heal, and I was very pleased with how the geko™ device performed. I thought that my condition was irreparable but the geko™ device helped my recovery”.

Benefits

Week 35

Prior to geko™ treatment.

Week 38

With geko™ treatment.

Week 58

Wound closed.

References

  1. NICE medical technologies guidance (MTG19). Published date: June 20 2014.
  2. Dimitri S, Pavey N, a targeted approach to healing complex wounds using the geko™ device, Firstkind Ltd, 2016.

OnPulse Technology

The revolutionary neuromuscular electrostimulation technology developed by Firstkind

Find out more

geko™ product

Wound Therapy Applications device

Find out more

Partner with us

What can the geko™ do for my patients?

News

Sky Medical Technology Launches New geko™ Website

News

The geko™ device makes breakthrough in
pre-operative oedema reduction

News

Sky Medical Technology & the South Tees Hospitals NHS Foundation trust win prestigious Bionow award